Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chun-Hou Liao

Showing results (1-10 of 104) with videos related to

Pageof 11
Sort By:
The Journal of Urology|November 27, 2012
Increased risk of large post-void residual urine and decreased long-term success rate after intravesical onabotulinumtoxinA injection for refractory idiopathic detrusor overactivityChun-Hou Liao, Hann-Chorng Kuo
International Neurourology Journal|January 8, 2016
Practical Aspects of Botulinum Toxin-A Treatment in Patients With Overactive Bladder SyndromeChun-Hou Liao, Hann-Chorng Kuo
Journal of the Formosan Medical Association = Taiwan Yi Zhi|September 3, 2018
Mirabegron escalation to 50 mg further improves daily urgency and urgency urinary incontinence in Asian patients with overactive bladderChun-Hou Liao, Hann-Chorng Kuo
Journal of Endourology|September 25, 2008
Laparoscopic adrenalectomy for a 6-cm left adrenal pheochromocytoma with needlescopic instrumentsChun-Hou Liao, Shih-Chieh Chueh
Urology|April 10, 2018
Mirabegron 25 mg Monotherapy Is Safe but Less Effective in Male Patients With Overactive Bladder and Bladder Outlet ObstructionChun-Hou Liao, Hann-Chorng Kuo
Tzu Chi Medical Journal|August 1, 2017
Current consensus and controversy on the treatment of male lower urinary tract symptoms/benign prostatic hyperplasiaChun-Hou Liao, Hann-Chorng Kuo
Medicine|November 10, 2016
High satisfaction with direct switching from antimuscarinics to mirabegron in patients receiving stable antimuscarinic treatmentChun-Hou Liao, Hann-Chorng Kuo
Toxins|February 23, 2020
Mechanism of Action of Botulinum Toxin A in Treatment of Functional Urological DisordersYu-Hua Lin, Bing-Juin Chiang, Chun-Hou Liao
Lower Urinary Tract Symptoms|July 2, 2016
Role of Bladder Dysfunction in Men with Lower Urinary Tract Symptoms Refractory to Alpha-blocker Therapy: A Video-urodynamic AnalysisYuan-Hong Jiang, Chun-Hou Liao, Hann-Chorng Kuo
European Urology|September 25, 2010
Adverse events of intravesical botulinum toxin a injections for idiopathic detrusor overactivity: risk factors and influence on treatment outcomeHann-Chorng Kuo, Chun-Hou Liao, Shiu-Dong Chung
Pageof 11

Showing results (1-10 of 104) with videos related to

Sort By:
Pageof 11
The Journal of Urology|November 27, 2012
Increased risk of large post-void residual urine and decreased long-term success rate after intravesical onabotulinumtoxinA injection for refractory idiopathic detrusor overactivityChun-Hou Liao, Hann-Chorng Kuo
International Neurourology Journal|January 8, 2016
Practical Aspects of Botulinum Toxin-A Treatment in Patients With Overactive Bladder SyndromeChun-Hou Liao, Hann-Chorng Kuo
Journal of the Formosan Medical Association = Taiwan Yi Zhi|September 3, 2018
Mirabegron escalation to 50 mg further improves daily urgency and urgency urinary incontinence in Asian patients with overactive bladderChun-Hou Liao, Hann-Chorng Kuo
Journal of Endourology|September 25, 2008
Laparoscopic adrenalectomy for a 6-cm left adrenal pheochromocytoma with needlescopic instrumentsChun-Hou Liao, Shih-Chieh Chueh
Urology|April 10, 2018
Mirabegron 25 mg Monotherapy Is Safe but Less Effective in Male Patients With Overactive Bladder and Bladder Outlet ObstructionChun-Hou Liao, Hann-Chorng Kuo
Tzu Chi Medical Journal|August 1, 2017
Current consensus and controversy on the treatment of male lower urinary tract symptoms/benign prostatic hyperplasiaChun-Hou Liao, Hann-Chorng Kuo
Medicine|November 10, 2016
High satisfaction with direct switching from antimuscarinics to mirabegron in patients receiving stable antimuscarinic treatmentChun-Hou Liao, Hann-Chorng Kuo
Toxins|February 23, 2020
Mechanism of Action of Botulinum Toxin A in Treatment of Functional Urological DisordersYu-Hua Lin, Bing-Juin Chiang, Chun-Hou Liao
Lower Urinary Tract Symptoms|July 2, 2016
Role of Bladder Dysfunction in Men with Lower Urinary Tract Symptoms Refractory to Alpha-blocker Therapy: A Video-urodynamic AnalysisYuan-Hong Jiang, Chun-Hou Liao, Hann-Chorng Kuo
European Urology|September 25, 2010
Adverse events of intravesical botulinum toxin a injections for idiopathic detrusor overactivity: risk factors and influence on treatment outcomeHann-Chorng Kuo, Chun-Hou Liao, Shiu-Dong Chung
Pageof 11